Literature DB >> 23734315

Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis.

Joonas H Kauppila1, Antti E Mattila, Tuomo J Karttunen, Tuula Salo.   

Abstract

Toll-like receptor 5 (TLR5) is an pattern recognition receptor expressed by several cells of the immune system that recognizes bacterial flagellin. We studied the influence of TLR5 in oral tongue squamous carcinoma and found that its expression levels predict patient survival and recurrence. Considering the role of microbiome in oral cancer, TLR5 may represent an important link between bacteria and oral oncogenesis.

Entities:  

Keywords:  Toll-like receptor 5; carcinoma; oral tongue squamous cell carcinoma

Year:  2013        PMID： 23734315      PMCID： PMC3654585          DOI： 10.4161/onci.23620

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Activation of TLR2 and TLR5 did not affect tumor progression of an oral squamous cell carcinoma, YD-10B cells.

Authors:  Jong-Hwan Park; Hyo-Eun Yoon; Do-In Jeon; Sang-Gun Ahn; Jung-Hoon Yoon
Journal:  J Oral Pathol Med       Date:  2010-11       Impact factor: 4.253

2.  Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth.

Authors:  Zhenyu Cai; Amir Sanchez; Zhongcheng Shi; Tingting Zhang; Mingyao Liu; Dekai Zhang
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

3.  Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma.

Authors:  Jong-Hwan Park; Hyo-Eun Yoon; Dong-Jae Kim; Soo-A Kim; Sang-Gun Ahn; Jung-Hoon Yoon
Journal:  J Oral Pathol Med       Date:  2010-08-31       Impact factor: 4.253

4.  Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.

Authors:  Pedro Pimentel-Nunes; Luís Afonso; Paula Lopes; Roberto Roncon-Albuquerque; Nádia Gonçalves; Rui Henrique; Luís Moreira-Dias; Adelino F Leite-Moreira; Mário Dinis-Ribeiro
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

5.  Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.

Authors:  Heikki Takala; Joonas H Kauppila; Ylermi Soini; Katri S Selander; Katri S Vuopala; Petri P Lehenkari; Juha Saarnio; Tuomo J Karttunen
Journal:  J Innate Immun       Date:  2011-08-29       Impact factor: 7.349

6.  Increased expression of Toll-like receptor 5 during progression of cervical neoplasia.

Authors:  W Y Kim; J-W Lee; J-J Choi; C H Choi; T-J Kim; B-G Kim; S Y Song; D-S Bae
Journal:  Int J Gynecol Cancer       Date:  2007-06-22       Impact factor: 3.437

Review 7.  Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.

Authors:  Shaherin Basith; Balachandran Manavalan; Tae Hyeon Yoo; Sang Geon Kim; Sangdun Choi
Journal:  Arch Pharm Res       Date:  2012-09-01       Impact factor: 4.946

8.  Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.

Authors:  Joonas H Kauppila; Tuomo J Karttunen; Juha Saarnio; Pia Nyberg; Tuula Salo; David E Graves; Petri P Lehenkari; Katri S Selander
Journal:  APMIS       Date:  2012-10-22       Impact factor: 3.205

9.  Oral microbiota and cancer.

Authors:  Jukka H Meurman
Journal:  J Oral Microbiol       Date:  2010-08-10       Impact factor: 5.474

10.  Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.

Authors:  J H Kauppila; A E Mattila; T J Karttunen; T Salo
Journal:  Br J Cancer       Date:  2013-01-03       Impact factor: 7.640
  10 in total
  11 in total

1.  A composite oral hygiene score and the risk of oral cancer and its subtypes: a large-scale propensity score-based study.

Authors:  Qingrong Deng; Lingjun Yan; Junyu Lin; Zhaocheng Zhuang; Yihong Hong; Chanchan Hu; Lisong Lin; Lizhen Pan; Bin Shi; Jing Wang; Fengqiong Liu; Lin Cai; Baochang He; Yu Qiu; Fa Chen
Journal:  Clin Oral Investig       Date:  2021-10-10       Impact factor: 3.606

2.  High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.

Authors:  Hui Zhou; Jian-hua Chen; Jun Hu; Yong-zhong Luo; Fang Li; Ling Xiao; Mei-zuo Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-19       Impact factor: 4.553

3.  Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort.

Authors:  Ngozi N Nwizu; James R Marshall; Kirsten Moysich; Robert J Genco; Kathleen M Hovey; Xiaodan Mai; Michael J LaMonte; Jo L Freudenheim; Jean Wactawski-Wende
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-08       Impact factor: 4.254

Review 4.  Toll-like receptors in esophageal cancer.

Authors:  Joonas H Kauppila; Katri S Selander
Journal:  Front Immunol       Date:  2014-05-07       Impact factor: 7.561

Review 5.  Classification of current anticancer immunotherapies.

Authors:  Lorenzo Galluzzi; Erika Vacchelli; José-Manuel Bravo-San Pedro; Aitziber Buqué; Laura Senovilla; Elisa Elena Baracco; Norma Bloy; Francesca Castoldi; Jean-Pierre Abastado; Patrizia Agostinis; Ron N Apte; Fernando Aranda; Maha Ayyoub; Philipp Beckhove; Jean-Yves Blay; Laura Bracci; Anne Caignard; Chiara Castelli; Federica Cavallo; Estaban Celis; Vincenzo Cerundolo; Aled Clayton; Mario P Colombo; Lisa Coussens; Madhav V Dhodapkar; Alexander M Eggermont; Douglas T Fearon; Wolf H Fridman; Jitka Fučíková; Dmitry I Gabrilovich; Jérôme Galon; Abhishek Garg; François Ghiringhelli; Giuseppe Giaccone; Eli Gilboa; Sacha Gnjatic; Axel Hoos; Anne Hosmalin; Dirk Jäger; Pawel Kalinski; Klas Kärre; Oliver Kepp; Rolf Kiessling; John M Kirkwood; Eva Klein; Alexander Knuth; Claire E Lewis; Roland Liblau; Michael T Lotze; Enrico Lugli; Jean-Pierre Mach; Fabrizio Mattei; Domenico Mavilio; Ignacio Melero; Cornelis J Melief; Elizabeth A Mittendorf; Lorenzo Moretta; Adekunke Odunsi; Hideho Okada; Anna Karolina Palucka; Marcus E Peter; Kenneth J Pienta; Angel Porgador; George C Prendergast; Gabriel A Rabinovich; Nicholas P Restifo; Naiyer Rizvi; Catherine Sautès-Fridman; Hans Schreiber; Barbara Seliger; Hiroshi Shiku; Bruno Silva-Santos; Mark J Smyth; Daniel E Speiser; Radek Spisek; Pramod K Srivastava; James E Talmadge; Eric Tartour; Sjoerd H Van Der Burg; Benoît J Van Den Eynde; Richard Vile; Hermann Wagner; Jeffrey S Weber; Theresa L Whiteside; Jedd D Wolchok; Laurence Zitvogel; Weiping Zou; Guido Kroemer
Journal:  Oncotarget       Date:  2014-12-30

Review 6.  Periodontal disease and cancer: Epidemiologic studies and possible mechanisms.

Authors:  Ngozi Nwizu; Jean Wactawski-Wende; Robert J Genco
Journal:  Periodontol 2000       Date:  2020-06       Impact factor: 7.589

7.  Oral hygiene and the overall survival of head and neck cancer patients.

Authors:  Chan-Chi Chang; Wei-Ting Lee; Jenn-Ren Hsiao; Chun-Yen Ou; Cheng-Chih Huang; Sen-Tien Tsai; Ken-Chung Chen; Jehn-Shyun Huang; Tung-Yiu Wong; Yu-Hsuan Lai; Yuan-Hua Wu; Wei-Ting Hsueh; Shang-Yin Wu; Chia-Jui Yen; Jang-Yang Chang; Chen-Lin Lin; Ya-Ling Weng; Han-Chien Yang; Yu-Shan Chen; Jeffrey S Chang
Journal:  Cancer Med       Date:  2019-03-13       Impact factor: 4.452

Review 8.  New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis.

Authors:  Shang-Hung Chen; Sheng-Yen Hsiao; Kwang-Yu Chang; Jang-Yang Chang
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

9.  Non-invasive imaging of Toll-like receptor 5 expression using 131I-labeled mAb in the mice bearing H22 tumors.

Authors:  Changya Yang; Qingying Yun; Hukui Sun; Guangjie Yang; Ting Liang; Chao Zhang; Jing Song; Jiankui Han; Guihua Hou
Journal:  Oncol Lett       Date:  2014-04-02       Impact factor: 2.967

10.  Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.

Authors:  Katy Mastorci; Elena Muraro; Elisa Pasini; Chiara Furlan; Luca Sigalotti; Marina Cinco; Riccardo Dolcetti; Elisabetta Fratta
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.